<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02550808</url>
  </required_header>
  <id_info>
    <org_study_id>ML-MTB-001</org_study_id>
    <nct_id>NCT02550808</nct_id>
  </id_info>
  <brief_title>Metabolic Changes in Patients With Chronic Cardiopulmonary Disease</brief_title>
  <official_title>Metabolic and Histological Changes in Skeletal Muscle and Fat Tissue in Patients With Chronic Cardiopulmonary Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>General and Teaching Hospital Celje</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Ljubljana</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>General Hospital Murska Sobota</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Maastricht University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>General and Teaching Hospital Celje</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims to evaluate prevalence of sarcopenia and cachexia in patients with chronic
      cardiopulmonary disease. The investigators will also investigate metabolic disorders like
      glucose metabolism, presence of metabolic syndrome, body composition and histological changes
      in skeletal muscle and body fat. Finally, patients will be followed for clinical endpoints.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2012</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">July 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Insulin resistance (HOMA-IR)</measure>
    <time_frame>Baseline</time_frame>
    <description>HOMA-IR as calculated by formula using insulin and blood glucose</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Muscle strength (Handgrip test)</measure>
    <time_frame>Baseline</time_frame>
    <description>Handgrip test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in exercise capacity (6 minute walk test)</measure>
    <time_frame>baseline and after 5 weeks</time_frame>
    <description>Determined by incremental exercise test, 6 minute walk test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Neurohormonal activation (NT-proBNP concentration)</measure>
    <time_frame>Baseline</time_frame>
    <description>NT-proBNP concentration</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in apoptosis in skeletal muscle (number of apoptotic cells per square mm)</measure>
    <time_frame>Baseline and after 5 weeks</time_frame>
    <description>histological evaluation: number of apoptotic cells per square mm</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Change in insulin resistance (HOMA-IR)</measure>
    <time_frame>Baseline and after 5 weeks</time_frame>
    <description>HOMA-IR as calculated by formula using insulin and blood glucose</description>
  </secondary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Heart Failure</condition>
  <condition>Chronic Obstructive Pulmonary Disease</condition>
  <condition>Malignancy</condition>
  <condition>Chronic Kidney Disease</condition>
  <arm_group>
    <arm_group_label>Heart failure</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Chronic obstructive pulmonary disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Chronic kidney disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Malignancy</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls</arm_group_label>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum; plasma; Skeletal muscle; fat tissue; urine; full blood
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with chronic disease (Heart failure, COPD, malignancy, CKD) and healthy controls
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  diagnosis of chronic disease (Heart failure, COPD, malignancy, CKD) or no diagnosis
             (controls)

        Exclusion Criteria:

          -  refuse to participate
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mitja Lainscak</last_name>
    <email>mitja.lainscak@guest.arnes.si</email>
  </overall_contact>
  <location>
    <facility>
      <name>General Hospital Celje</name>
      <address>
        <city>Celje</city>
        <zip>SI-3000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mitja Lainscak, MD, PhD</last_name>
      <email>mitja.lainscak@guest.arnes.si</email>
    </contact>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 3, 2015</study_first_submitted>
  <study_first_submitted_qc>September 15, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 16, 2015</study_first_posted>
  <last_update_submitted>September 15, 2015</last_update_submitted>
  <last_update_submitted_qc>September 15, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 16, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>General and Teaching Hospital Celje</investigator_affiliation>
    <investigator_full_name>Mitja Lainscak</investigator_full_name>
    <investigator_title>Professor of Internal Medicine</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Lung Diseases</mesh_term>
    <mesh_term>Kidney Diseases</mesh_term>
    <mesh_term>Lung Diseases, Obstructive</mesh_term>
    <mesh_term>Pulmonary Disease, Chronic Obstructive</mesh_term>
    <mesh_term>Renal Insufficiency, Chronic</mesh_term>
    <mesh_term>Pulmonary Heart Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

